Early Development of Acute Myelogenous Leukemia Following Kidney Transplantation: Possible Role of Multiple Serum Cytokines

References

• Thomas J.A., Hotchin N.A., Allday M.J., et al. Immunohistology of Epstein-Barr virus-associated antigens in B cell disorders from immunocompromised individuals. Transplantation 1990; 49: 944–953
   PubMed Web of Science ®Google Scholar
• Cantley L.C., Auger K.R., Carpenter C. Oncogenes and signal transduction. Cell 1991; 64: 281–302
   PubMed Web of Science ®Google Scholar
• Rabbits T.H. Translocations. Master Genes, and differences between the origins of acute and chronic leukemias. Cell 1991; 67: 641–644
   PubMed Web of Science ®Google Scholar
• Cleary M.L. Oncogenic conversion of transcription factors by chromosomal translocations. Cell 1991; 66: 619–622
   PubMed Web of Science ®Google Scholar
• Hartwell L. Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell. 1992; 71: 543–546
   PubMed Web of Science ®Google Scholar
• Marshall C.J. Tumor suppressor genes. Cell 1991; 64: 313–326
   PubMed Web of Science ®Google Scholar
• Cross M., Dexter T.M. Growth factors in development, transformation, and tumorigenesis. Cell 1991; 64: 271–280
   PubMed Web of Science ®Google Scholar
• Hunter T. Cooperation between oncogenes. Cell 1991; 64: 249–270
   PubMed Web of Science ®Google Scholar
• Sawyers C.L., Denny C.T., Witte O.N. Leukemia and the disruption of normal hematopoiesis. Cell. 1991; 64: 337–350
   PubMed Web of Science ®Google Scholar
• Burke G.W., Cirocco R., Hensley G., et al. The rapid development of a fatal, disseminated B cell lymphoma following liver transplantation—serial changes in levels of soluble serum interleukin 2 and interleukin 4 (B cell growth factor). Transplantation 1992; 53(5)1148–1150
   PubMed Web of Science ®Google Scholar
• Cannistra S.A. Growth regulation of malignant clonogenic cells in acute myeloid leukemia. Current Opinion Oncol. 1991; 3: 4–12
   PubMedGoogle Scholar
• Souyri M., Vigon I., Penciolelli J.F., Heard J.M., Tambourin P., Wendling F. A putative truncated cytokine receptor gene transduced by the myeloproliferative leukemia virus immortalizes hematopoietic progenitors. Cell 1990; 63: 1137–1147
   PubMed Web of Science ®Google Scholar
• Young D.C., Griffin J.D. Autocrine secretion of GM-CSF in acute myeloblastic leukemia. Blood 1986; 68: 1178–1181
   PubMed Web of Science ®Google Scholar
• Budel L.M., Touw I.P., Delwel R., Clark S.C., Löwenberg B. Interleukin-3 and granulocyte-monocyte colony-stimulating factor receptors on human acute myelocytic leukemia cells and relationship to the proliferative response. Blood 1989; 74: 565–71
   PubMed Web of Science ®Google Scholar
• Löwenberg B., van Putten W.L.J., Touw I.P., Delwell R., Santini V. Autonomous proliferation of leukemic cells in vitro as a determinant of prognosis in adult acute myeloid leukemia. N. Engl. J. Med. 1993; 328: 614–619
   PubMed Web of Science ®Google Scholar
• Vairo G., Hamilton J.A. Signalling through CSF receptors. Immunol, Today. 1991; 12(10)362–369
   PubMedGoogle Scholar
• Lopez A.F., Elliott M.J., Woodcock J., Vadas M.A. GM-CSF. IL-3 and IL-5: cross-competition on human hacmopoietic cells. Immunol. Today 1992; 13(12)495–500
   PubMedGoogle Scholar
• Hallek M., Lepisto E.M., Slaterry K.E., Griffin J.D., Ernst T.J. Interferon-y increases the expression of the gene encoding the β subunit of the granulocyte-macrophage colony-stimulating factor receptor. Blood 1992; 80(7)1736–1742
   PubMed Web of Science ®Google Scholar
• Murohashi I., Hoang T. Interferon-y enhances growth factor-dependent proliferation of clonogenic cells in acute myeloblastic leukemia. Blood 1991; 78(4)1085–1095
   PubMed Web of Science ®Google Scholar
• Elbaz O., Budel L.M., Hoogerbrugge H., et al. Tumor necrosis factor regulates the expression of granulocyte-macrophage colony-stimulating factor and interleukin-3 receptors on human acute myeloid leukemia cells. Blood 1991; 77(5)989–995
   PubMed Web of Science ®Google Scholar
• Rodriguez-Cimadevilla J.C., Beauchemin V., Villeneuve L., Letendre F., Shaw A., Hoang T. Coordinate secretion of interleukin-P and granulocyte-macrophage colony-stimulating factor by the blast cells of acute myeloblastic leukemia: Role of interleukin- I as an endogenous inducer. Blood. 1990; 76(8)1481–1489
   PubMed Web of Science ®Google Scholar
• Onetto-Pothier N., Aumont N., Haman A., et al. IL-3 inhibits the binding of GM-CSF to AML blasts. but the two cytokines act synergistically in supporting blast proliferation. Leukemia. 1990; 4(5)5, 329–336
   Google Scholar
• O'Brien D., Boughton B. High and low affinity IL-2 receptors on human leukaemic blast cells. Br. J. Haematol. 1990; 76(2)315–317
   PubMed Web of Science ®Google Scholar
• Carron J.A., Cawley I.C. IL-2 myelopoiesis: IL-2 induces blast cell proliferation in some cases of acute myeloid leukaemia. Br. J. Haematol. 1989; 73: 168–172
   PubMed Web of Science ®Google Scholar
• Foa R., Caretto P., Fierro M.T., et al. Interleukin-2 does not promote the in vitro and in vivo proliferation and growth of human acute leukaemia cells of myeloid and lymphoid origin. Br. J. Haematol. 1990; 75: 34–40
   PubMed Web of Science ®Google Scholar
• Cimino G., Amadori S., Cava M.C., et al. Serum inter-leukin-2 (IL-2). soluble IL-2 receptors and tumor necrosis factor-alpha levels are significantly increased in acute myeloid leukemia patients. Leukemia 1991; 5(1)32–35
   PubMed Web of Science ®Google Scholar
• Akashi K., Harada M., Shibuya T., et al. Effects of inter-leukin-4 and interleukin-6 on the proliferation of CD34 and CD34 blasts from acute myelogenous leukemia. Blood. 1991; 78(1)197–204
   PubMed Web of Science ®Google Scholar
• Hamilton J.A., Whitty G.A., Royston A.K., Cebon J., Layton J.E. Interleukin-4 suppresses granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor levels in stimulating factor levels in stimulated human monocytcs. Immunology 1992; 76: 566–571
   PubMed Web of Science ®Google Scholar
• Hetherington S.V., Quie P.G. Human polymorphonuclear leukocytes of the bone marrow, circulation, and marginated pool: Function and granule protein content. American Journal of Hematology 1985; 20: 235–246
   PubMed Web of Science ®Google Scholar
• van de Stolpe A., Caldenhoven E., Raaijmakers J.A.M., Van der Saag P.T., Koenderman L. Glucocorticoid-mediated repression of intercellular adhesion molecule-I expression in human monocytic and bronchial epithelial cell lines. Am J. Respir, Cell. Mol. Biol 1993; 8: 340–347
   PubMed Web of Science ®Google Scholar
• Lowry R.P. The relationship of IL-4. IL-10 and other cytokines to transplantation tolerance. Transplantation Sci. 1993; 3: 104–112
   Google Scholar
• Paliogianni F., Ahuja S.S., Balow J.P., Balow J.E., Boumpas D.T. Novel mechanism for inhibition of human T cells by glucocorticoids. Glucocorticoids inhibit signal transduction through IL-2 receptor. J. Immunology 1993; 151(8)4081–4089
   PubMed Web of Science ®Google Scholar
• Benjamin D., Knobloch T.J., Dayton M.A. Human B-cell interleukin-10: B-cell lines derived from patients with acquired immunodeficiency syndrome and Burkitt's lymphoma constitutively secrete large quantities of interleukin-10. Blood 1992; 80(5)1289–1298
   PubMed Web of Science ®Google Scholar
• Penn I. The effect of immunosuppression on preexisting cancers. Transplantation 1993; 55(4)742–747
   PubMed Web of Science ®Google Scholar
• Barrett W.L., First M.R., Aron B.S., Penn I. Clinical course of malignancies in renal transplant recipients. Cancer 1993; 72: 2186–2189
   PubMed Web of Science ®Google Scholar
• Streilein J.W., Taylor J.R., Vincek V. Immune surveillance and sunlight-induced skin cancer. Immunology Today. 1994; 15(4)174–179
   PubMedGoogle Scholar
• Yefenof E., Abboud G., Epszteyn S., Vitetta E.S. Treatment of premalignancy: Prevention of lymphoma in radiation leukemia virus-inoculated mice by cyclosporin A and immunotoxin. Proc, Nail. Acad Sci. USA 1992; 89: 728–732
   PubMed Web of Science ®Google Scholar
• Forster E., Kirnbauer R., Urbanski A., et al. Human melanoma cells produce interleukin 8 which functions as an autocrine growth factor. Clin, Res. 1991; 39: 517A
   PubMedGoogle Scholar
• Richmond A. The pathogenic role of growth factors in melanoma. Semin, Dermatol. 1991; 10: 246–255
   PubMedGoogle Scholar
• Gnss H.J., Brach M.A., Drexler H.G., Bross K.J., Herrman F. Interleukin 9 is expressed by primary and cultured Hodgkin and Reed-Sternberg cells. Cancer Res. 1992; 52: 1026–1031
   PubMed Web of Science ®Google Scholar
• Uyttenhove C., Druez C., Renauld J.C., Herin M., Noel H., van Snick J. Autonomous growth and tumorigenicity induced by P40/Interleukin 9 cDNA transfection of a mouse P40-dependent T cell line. J. Exp. Med. 1991; 173: 519–522
   PubMed Web of Science ®Google Scholar
• Migliaccio G., Migliaccio A.R., Ruscetti S., Adamson J.W. The growth of Rauscher erythroleukemia cells in mediated by autocrine production of a factor with biological activity similar to interleukin-3. Blood. 1989; 73: 1770–1777
   PubMed Web of Science ®Google Scholar
• Mitjavila Le M.T., Codevic J.P., Casadevall N., Navarro S., Villeval J.L. Autocrine stimulation by erythropoietin and autonomous growth of human erythroid leukemia cells in vitro. J. Clin, Invest. 1991; 88: 789–797
   PubMed Web of Science ®Google Scholar
• Palumbo G.A., Cacciola E., Guglielmo P., Giustolisi R., Cacciola E. Relationship between growth factors, oncogenes and cytokines in the mechanism of aberrant hematopoieses. Hemopoietic Growth Factors. Oncogenes and Cytokines in Clinical Hematology, E. Cacciola, A.B. Deisseroth, R. Giustolisi. Karger, Basel 1994; 1–21
   Google Scholar